News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
Merck KGaA discontinues phase III trials of xevinapant in locally advanced head & neck cancer after interim analysis results. Xevinapant is currently under clinical investigation -
-
-
-